INVO Fertility (NASDAQ:IVF – Get Free Report) released its quarterly earnings data on Monday. The company reported ($2.44) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $2.22 million for the quarter. INVO Fertility had a negative net margin of 103.33% and a negative return on equity of 54.51%.
INVO Fertility Trading Down 4.8%
Shares of NASDAQ:IVF traded down $0.10 during midday trading on Wednesday, reaching $2.08. The company’s stock had a trading volume of 14,979 shares, compared to its average volume of 426,504. INVO Fertility has a fifty-two week low of $1.59 and a fifty-two week high of $91.60. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.67 and a current ratio of 0.71. The firm has a 50 day moving average price of $9.89 and a two-hundred day moving average price of $30.39. The firm has a market capitalization of $1.31 million, a price-to-earnings ratio of -0.02 and a beta of 2.42.
Analyst Ratings Changes
IVF has been the subject of a number of recent research reports. Wall Street Zen raised INVO Fertility to a “hold” rating in a report on Saturday, August 29th. Weiss Ratings reissued a “sell (e+)” rating on shares of INVO Fertility in a research note on Friday, October 30th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, INVO Fertility has an average rating of “Moderate Buy” and an average target price of $320.00.
About INVO Fertility
INVO Fertility is a fertility-care company that develops and provides treatments for people seeking to build a family. Its offerings include fertility services through its clinics and the INVOcellĀ® system, a device and procedure that allows fertilization and early embryo development to take place inside the patient’s body. The company’s approach is an alternative to conventional in vitro fertilization, while also offering fertility care through its clinic operations. INVO Fertility has pursued growth by expanding its network of fertility centers in the United States and by making its technology available in international markets.
Featured Articles
- Five stocks we like better than INVO Fertility
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
Receive News & Ratings for INVO Fertility Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Fertility and related companies with MarketBeat.com's FREE daily email newsletter.
